|
Market Closed -
Toronto S.E.
01:23:15 10/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.4600 CAD | -1.08% |
|
-3.16% | +1.10% |
| 27/08 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 20/08 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.6667 | +44.93% | 3 | ||||||
| 58.56 | +94.05% | 16 | ||||||
| 3,035 | +19.96% | 10 | ||||||
| 4.621 | +77.03% | 15 | ||||||
| 31.29 | +37.17% | 13 | ||||||
| 120.63 | +29.85% | 9 | ||||||
| 23.75 | +29.92% | 8 | ||||||
| 318.71 | +67.12% | 7 | ||||||
| 48.83 | +12.55% | 6 | ||||||
| - | - | 1,415 | +214.47% | 1 | ||||
| 37.07 | +42.04% | 7 | ||||||
| 87.5 | +66.03% | 10 | ||||||
| 13.19 | +16.93% | 5 | ||||||
| 49.2 | +26.15% | 8 | ||||||
| 1,013.14 | +51.23% | 7 | ||||||
| - | 92.5 | +21.79% | 2 | |||||
| Average | 396.85 | +53.20% | 8 | ||||||
| Weighted average by Cap. | 518.82 | +63.97% | 11 |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
